SCHEMBL14348174

SCHEMBL14348174

CC(C)(CO)CNCc1ccc(Cl)c(C(=O)NCC23CCCC4CC(CC4C2)C3)c1

nearest known ligand 0.49

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 19/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7085048 0.89 P2RX7 (0.48) P2RX7
SCHEMBL4137642 0.88 P2RX7 (0.61) P2RX7
SCHEMBL14402966 0.86 P2RX7 (0.57) P2RX7
SCHEMBL14347720 0.86 P2RX7 (0.57) P2RX7
SCHEMBL14347206 0.84 P2RX7 (0.53) P2RX7
SCHEMBL14347641 0.84 P2RX7 (0.60) P2RX7
SCHEMBL14347721 0.83 P2RX7 (0.54) P2RX7
SCHEMBL14347205 0.83 P2RX7 (0.52) P2RX7
SCHEMBL14347576 0.83 P2RX7 (0.52) P2RX7
SCHEMBL14272604 0.81 P2RX7 (0.55) P2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1862451-A1 Adamantane derivatives for the treatment of inflammatory diseases AstraZeneca AB (SE) 2007-12-05 EP disclosed